SICKLE CELL ANEMIA TESTING AND SCREENING MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024 - 2031)

Sickle Cell Anemia Testing and Screening Market, By Testing Method (Hemoglobin Electrophoresis, High-Performance Liquid Chromatography (HPLC), Point-of-Care Tests, Genetic Testing, and Others), By Age Group (Newborn Screening, Ages 1 to 25, and Ages 26 and Above), By Sector (Government Labs, Private Labs, Corporate Labs, and PPP), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)

In October 2024, Bio-Rad Laboratories, a life science company, introduced the Vericheck ddPCR , Droplet Digital PCR (ddPCR) Droplet Digital PCR technology, Empty-Full Capsid Kit, to analyze Adeno-associated virus (AAV) samples for capsid and genome titer, as well as the proportion of full capsids. This cost-efficient solution delivers precise, reproducible results, streamlining gene therapy development while ensuring regulatory compliance.
In April 2024, Streck, a manufacturer of laboratory products, launched Protein Plus BCT, a blood collection tube designed to stabilize blood protein levels during storage. This innovation preserves sample quality for mass spectrometry and immunoassay analysis, providing laboratories greater logistical flexibility without compromising accuracy.
In January 2024, the Ministry of Health and Family Welfare announced a milestone achievement of screening over 10 Mn individuals for Sickle Cell Disease (SCD) under the National Sickle Cell Anaemia Elimination Mission. Launched on July 1, 2023, by the Prime Minister in Shahdol, Madhya Pradesh, the mission aims to screen 70 Mn people in 3 years. Focused on 278 districts across 17 states, including Gujarat, Maharashtra, and Madhya Pradesh in India the initiative targets high-prevalence tribal and non-tribal regions to screen, prevent, and manage SCD comprehensively.